Maravai LifeSciences Ownership | Who Owns Maravai LifeSciences?


OverviewForecastRevenueFinancialsChartTranscripts

Maravai LifeSciences Ownership Summary


Maravai LifeSciences is owned by 13.14% institutional investors, 10.14% insiders, and 76.72% retail investors. Gtcr is the largest institutional shareholder, holding 13.97% of MRVI shares. Canada Life US Small-Mid Cap Growth A is the top mutual fund, with 3.22% of its assets in Maravai LifeSciences shares.

MRVI Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockMaravai LifeSciences13.14%10.14%76.72%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Gtcr20.15M13.97%$57.83M
12 west capital management lp12.52M8.68%$35.94M
Blackrock9.73M7.35%$69.66M
Blackrock funding, inc. /de9.10M6.31%$26.13M
Braidwell lp8.35M5.79%$23.97M
Vanguard group7.13M4.94%$20.45M
T. rowe price investment management6.16M4.27%$17.68M
Mackenzie financial6.07M4.21%$17.42M
Renaissance4.32M2.99%$12.39M
Mirabella financial services llp3.75M2.60%$10.76M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Gtcr20.15M6.38%$57.83M
12 west capital management lp12.52M3.73%$35.94M
Tejara capital2.45M3.67%$7.04M
Mirabella financial services llp3.75M0.89%$10.76M
Braidwell lp8.35M0.71%$23.97M
Monaco asset management sam3.66M0.64%$10.49M
Point72 (difc)2.59M0.49%$7.43M
Philosophy capital management2.59M0.30%$7.44M
Delta investment management470.14K0.24%$1.35M
Centerbook partners lp1.69M0.24%$4.86M

Top Buyers

HolderShares% AssetsChange
T. rowe price investment management6.16M0.01%3.51M
Blackrock9.73M0.00%3.31M
Monaco asset management sam3.66M0.64%2.78M
Marshall wace, llp1.31M0.00%990.91K
Tejara capital2.45M3.67%511.99K

Top Sellers

HolderShares% AssetsChange
Alyeska investment group---5.33M
Jennison associates---2.99M
Millennium management1.91M0.01%-2.42M
First trust advisors lp---2.40M
Vanguard group7.13M0.00%-2.26M

New Positions

HolderShares% AssetsChangeValue
First eagle investment management450.93K0.00%450.93K$1.29M
General american investors136.41K0.02%136.41K$391.49K
Atom investors lp55.05K0.01%55.05K$157.99K
Y-intercept (hong kong)33.77K0.00%33.77K$96.93K
Point72 asset management32.74K0.00%32.74K$93.97K

Sold Out

HolderChange
Sjs investment consulting-2.00
Jfs wealth advisors-5.00
True wealth design-9.00
Steward partners investment advisory-20.00
Assetmark-21.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202552-65.79%18,956,142-85.37%130.16%21-73.08%16-60.98%
Jun 30, 2025151-21.35%129,251,4490.45%891.11%77-26.67%41-21.15%
Mar 31, 20251901.60%128,243,066-8.54%890.91%10311.96%52-16.13%
Dec 31, 2024172-21.82%136,455,890-5.23%960.93%81-27.68%59-13.24%
Sep 30, 20242206.80%143,991,590-2.29%1010.82%113-68-1.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Canada Life US Small-Mid Cap Growth A4.57M3.22%-
Canada Life US Small-Mid Cap Growth F4.57M3.16%-
Vanguard US Total Market Shares ETF3.94M2.74%547.00K
Vanguard Total Stock Mkt Idx Inv3.93M2.72%-86.69K
iShares Russell 2000 ETF3.00M2.08%-
Glenmede Small Cap Equity Adv2.03M1.43%-14.85K
Glenmede Small Cap Equity2.03M1.43%-14.85K
MFS New Discovery Value I2.01M1.42%-28.80K
T. Rowe Price Small-Cap Stock1.96M1.35%1.96M
JPMorgan Small Cap Growth A1.94M1.35%-21.81K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 05, 2025LUCIER GREGORY T-Buy$190.45K
Dec 08, 2025LUCIER GREGORY T-Buy$178.10K
Nov 13, 2025Brust Bernd Chief Executive OfficerBuy$702.69K
Nov 12, 2025Brust Bernd Chief Executive OfficerBuy$299.68K
Nov 11, 2025Brust Bernd Chief Executive OfficerBuy$509.33K

Insider Transactions Trends


DateBuySell
2025 Q45-
2025 Q3--
2025 Q2--
2025 Q1-1
2024 Q42-

MRVI Ownership FAQ


Who Owns Maravai LifeSciences?

Maravai LifeSciences shareholders are primarily institutional investors at 13.14%, followed by 10.14% insiders and 76.72% retail investors. The average institutional ownership in Maravai LifeSciences's industry, Biotech Stocks , is 45.22%, which Maravai LifeSciences falls below.

Who owns the most shares of Maravai LifeSciences?

Maravai LifeSciences’s largest shareholders are Gtcr (20.15M shares, 13.97%), 12 west capital management lp (12.52M shares, 8.68%), and Blackrock (9.73M shares, 7.35%). Together, they hold 30.00% of Maravai LifeSciences’s total shares outstanding.

Does Blackrock own Maravai LifeSciences?

Yes, BlackRock owns 7.35% of Maravai LifeSciences, totaling 9.73M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 69.66M$. In the last quarter, BlackRock increased its holdings by 3.31M shares, a 51.67% change.

Who is Maravai LifeSciences’s biggest shareholder by percentage of total assets invested?

Gtcr is Maravai LifeSciences’s biggest shareholder by percentage of total assets invested, with 6.38% of its assets in 20.15M Maravai LifeSciences shares, valued at 57.83M$.

Who is the top mutual fund holder of Maravai LifeSciences shares?

Canada Life US Small-Mid Cap Growth A is the top mutual fund holder of Maravai LifeSciences shares, with 3.22% of its total shares outstanding invested in 4.57M Maravai LifeSciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools